Midazolam Kalceks (Midazolam)

• Midazolam is a benzodiazepine used across several clinical pathways that require rapid central nervous system depression.
• Procedural sedation: enables safe and controlled sedation for minor surgical or diagnostic procedures.
• Pre‑anesthetic medication: reduces anxiety and facilitates induction of anesthesia.
• Anxiety relief: provides short‑term anxiolysis in acute stress situations.
• Status epilepticus: terminates ongoing seizures when other therapies are insufficient.
• Short‑term insomnia: induces sleep for brief periods when other treatments are unsuitable.

• Midazolam acts as a positive allosteric modulator of the GABA‑A receptor complex. By binding to a distinct site on the receptor, it enhances the inhibitory effect of gamma‑aminobutyric acid, increasing chloride ion influx and hyperpolarizing neuronal membranes. This potentiation of GABAergic transmission leads to sedation, anxiolysis, muscle relaxation, and anticonvulsant activity.

Midazolam may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Drowsiness: excessive sleepiness or reduced alertness.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Hypotension: lowered blood pressure, especially with rapid IV administration.
• Respiratory depression: slowed breathing, particularly at higher doses.
• Nausea: mild stomach upset or urge to vomit.
• Amnesia: short‑term memory loss surrounding the procedure.

Serious or Rare Side Effects

• Severe respiratory compromise requiring assisted ventilation.
• Paradoxical reactions such as agitation or aggression.
• Cardiac arrhythmias: irregular heart rhythms.
• Allergic reactions: rash, itching, or anaphylaxis.
• Withdrawal symptoms on abrupt discontinuation after prolonged use.
• Hepatic dysfunction: elevated liver enzymes in susceptible individuals.

• Midazolam requires careful assessment before use to minimize risks.
• Renal or hepatic impairment: adjust dosing and monitor closely.
• Elderly patients: start with lower doses due to increased sensitivity.
• Concomitant CNS depressants: avoid additive sedation and respiratory depression.
• Pregnancy Category D: use only if benefits outweigh potential fetal risks.
• Breastfeeding: consider alternative agents as drug may pass into milk.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Midazolam interacts with several drug classes that can alter its safety profile.

Major Interactions (Avoid)

• Opioids (e.g., fentanyl, morphine): synergistic respiratory depression.
• Barbiturates (e.g., phenobarbital): profound CNS depression.
• Macrolide antibiotics (e.g., erythromycin): increase plasma concentrations.
• Azole antifungals (e.g., ketoconazole): inhibit metabolism, raising levels.
• CYP3A4 inhibitors (e.g., ritonavir): elevate systemic exposure.

Moderate Interactions (Monitor Closely)

• Antidepressants (e.g., fluoxetine): may enhance sedative effect.
• Antihistamines (e.g., diphenhydramine): additive drowsiness.
• Alcohol: potentiates CNS depression.
• Anticonvulsants (e.g., carbamazepine): may reduce efficacy.
• Herbal supplements (e.g., St. John’s wort): induce metabolism, lowering effect.